Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer

GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global […]

Read more

Pacific Green Signs Battery Energy Storage System Strategic Manufacturing Framework Memorandum of Understanding with Shanghai Electric Gotion New Energy Technology CO., LTD.

DOVER, DE / ACCESSWIRE / January 14, 2021 / Pacific Green Technologies, Inc. (the “Company” or “PGTK,” (OTCQB:PGTK)) announces the signing of a Battery Energy Storage System Strategic Manufacturing Framework Agreement Memorandum of Understanding (the “Framework Agreement”) with Shanghai Electric Gotion New Energy Technology Co., Ltd. (“SEG”). Under the terms of the Framework Agreement, the […]

Read more

Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™

Glow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with successful Phase II Clinical Results The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and […]

Read more

RoosterBio Partners with Sartorius to Advance Cell and Gene Therapy Manufacturing

RoosterBio’s innovative hMSCs and bioprocess media systems, coupled with Sartorius’s scalable closed system bioreactor, downstream processing, and analytics, offers end-to-end hMSC manufacturing solutions for the field of regenerative medicine. FREDERICK, Md., Jan. 14, 2021 (GLOBE NEWSWIRE) — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media and […]

Read more

Philips and Merck partner to advance personalized fertility treatment

January 14, 2021 Remote patient monitoring, cloud-based platform services and mobile, AI-enabled ultrasound diagnostics to support improved access to care and better outcomes in fertility treatment Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, […]

Read more

Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance

WASHINGTON, Jan. 13, 2021 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) announced today that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 vaccine. The grants are part of Sabin’s Social and […]

Read more

Constellation Brands Completes Series of Transactions to Premiumize Portfolio With Sale of Paul Masson Grande Amber Brandy to Sazerac

VICTOR, N.Y., Jan. 12, 2021 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it has closed its sale of the Paul Masson Grande Amber Brandy brand, related inventory, and interests in certain contracts to Sazerac for approximately $265 million, subject to certain post-closing adjustments. “The closure […]

Read more

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables […]

Read more

SweeGen Announces Successful Scale-up of Bestevia® Reb N

Further expands the sweet taste solution toolbox for tackling sugar reduction. Rancho Santa Margarita, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — SweeGen is making possible a healthier, more guilt-free, and sweeter world with the commercialization of Bestevia® Rebaudioside N (Reb N), a special zero-calorie, highly sought-after natural stevia sweetener. Reb N is a naturally occurring […]

Read more

Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities

Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities Lugano, Switzerland, January 12, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, today announces the first patient has been dosed in a Phase 1/2 Study […]

Read more